Found 5 results

Name Type of Offering Accepted Date
Acer Therapeutics Inc. See All Filings
D 2015-04-01
Amount To Be Raised $2,100,000
Associated Brokers / Dealers N/A
CIK Number 0001638234
Filed Document 0001638234-15-000001
Exclusions or Exemptions 506b
Accepted Date 2015-04-01
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Debt
Acer Therapeutics Inc. See All Filings
D/A 2016-05-06
Amount To Be Raised $8,149,999
Associated Brokers / Dealers N/A
CIK Number 0001638234
Filed Document 0001638234-16-000003
Exclusions or Exemptions 506b
Accepted Date 2016-05-06
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Acer Therapeutics Inc. See All Filings
D 2017-04-05 15:14:22
Amount To Be Raised $5,500,000
Associated Brokers / Dealers N/A
CIK Number 0001638234
Filed Document 0001638234-17-000001
Exclusions or Exemptions 506b
Accepted Date 2017-04-05 15:14:22
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Debt
Acer Therapeutics Inc. See All Filings
D 2016-05-05
Amount To Be Raised $8,149,999
Associated Brokers / Dealers N/A
CIK Number 0001638234
Filed Document 0001638234-16-000002
Exclusions or Exemptions 506b
Accepted Date 2016-05-05
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Acer Therapeutics Inc. See All Filings
D 2017-10-04 13:58:34
Amount To Be Raised $15,674,384
Associated Brokers / Dealers N/A
CIK Number 0001638234
Filed Document 0001638234-17-000002
Exclusions or Exemptions 506b
Accepted Date 2017-10-04 13:58:34
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity